Compare ROCK & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ROCK | SLNO |
|---|---|---|
| Founded | 1972 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.5B |
| IPO Year | 1993 | 2014 |
| Metric | ROCK | SLNO |
|---|---|---|
| Price | $50.57 | $48.31 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $110.90 |
| AVG Volume (30 Days) | 345.6K | ★ 1.6M |
| Earning Date | 10-30-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.13 | N/A |
| Revenue | ★ $1,383,811,000.00 | $98,675,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.98 | $155.86 |
| P/E Ratio | $11.17 | ★ N/A |
| Revenue Growth | ★ 23.49 | N/A |
| 52 Week Low | $42.86 | $41.50 |
| 52 Week High | $75.08 | $90.32 |
| Indicator | ROCK | SLNO |
|---|---|---|
| Relative Strength Index (RSI) | 41.35 | 42.58 |
| Support Level | $50.00 | $48.60 |
| Resistance Level | $51.96 | $50.95 |
| Average True Range (ATR) | 1.51 | 2.63 |
| MACD | 0.60 | 0.21 |
| Stochastic Oscillator | 32.81 | 9.24 |
Gibraltar Industries Inc manufactures and provides products and services for the Renewable energy, Residential, Agtech, and Infrastructure markets. The Renewables Segment is engaged in designing, engineering, manufacturing, and installing solar racking and electrical balance systems. Agtech Segment provides growing and processing solutions including the designing, engineering, manufacturing, full-scope construction, maintenance, and support of greenhouses and indoor growing operations, and botanical extraction systems. It derives key revenue from the Residential segment which offers roof and foundation ventilation products, single point and centralized mail systems electronic package solutions, and Retractable awnings and gutter guards, among other products.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.